American Century Companies’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$467K Buy
44,161
+10,909
+33% +$115K ﹤0.01% 2543
2025
Q1
$500K Buy
33,252
+3,361
+11% +$50.5K ﹤0.01% 2510
2024
Q4
$492K Buy
29,891
+2,553
+9% +$42K ﹤0.01% 2510
2024
Q3
$675K Buy
27,338
+3,446
+14% +$85.1K ﹤0.01% 2372
2024
Q2
$605K Buy
23,892
+2,518
+12% +$63.8K ﹤0.01% 2370
2024
Q1
$543K Buy
21,374
+5,715
+36% +$145K ﹤0.01% 2424
2023
Q4
$355K Buy
15,659
+4,127
+36% +$93.5K ﹤0.01% 2495
2023
Q3
$215K Buy
11,532
+2,595
+29% +$48.3K ﹤0.01% 2570
2023
Q2
$232K Buy
+8,937
New +$232K ﹤0.01% 2486
2020
Q3
Sell
-11,007
Closed -$415K 1805
2020
Q2
$415K Sell
11,007
-7,146
-39% -$269K ﹤0.01% 1341
2020
Q1
$525K Buy
18,153
+93
+0.5% +$2.69K ﹤0.01% 1151
2019
Q4
$936K Sell
18,060
-34,898
-66% -$1.81M ﹤0.01% 1098
2019
Q3
$2.91M Sell
52,958
-15,050
-22% -$826K ﹤0.01% 906
2019
Q2
$2.76M Buy
68,008
+36,727
+117% +$1.49M ﹤0.01% 971
2019
Q1
$946K Buy
+31,281
New +$946K ﹤0.01% 1065
2018
Q4
Sell
-15,039
Closed -$634K 1233
2018
Q3
$634K Hold
15,039
﹤0.01% 1152
2018
Q2
$481K Buy
15,039
+10,068
+203% +$322K ﹤0.01% 1193
2018
Q1
$247K Buy
+4,971
New +$247K ﹤0.01% 1213
2016
Q3
Sell
-35,125
Closed -$1.88M 1327
2016
Q2
$1.88M Sell
35,125
-18,688
-35% -$1M ﹤0.01% 1039
2016
Q1
$2.41M Buy
53,813
+2,296
+4% +$103K ﹤0.01% 965
2015
Q4
$1.97M Buy
51,517
+411
+0.8% +$15.7K ﹤0.01% 1020
2015
Q3
$1.63M Sell
51,106
-38,316
-43% -$1.22M ﹤0.01% 1041
2015
Q2
$2.95M Sell
89,422
-14,775
-14% -$488K ﹤0.01% 977
2015
Q1
$4.29M Sell
104,197
-809
-0.8% -$33.3K ﹤0.01% 885
2014
Q4
$4.28M Buy
105,006
+18
+0% +$733 ﹤0.01% 903
2014
Q3
$3.85M Buy
104,988
+18,864
+22% +$692K ﹤0.01% 941
2014
Q2
$3.99M Buy
86,124
+8,229
+11% +$381K ﹤0.01% 959
2014
Q1
$3.2M Sell
77,895
-29,591
-28% -$1.22M ﹤0.01% 1027
2013
Q4
$4.1M Buy
107,486
+35,801
+50% +$1.37M ﹤0.01% 958
2013
Q3
$1.72M Buy
71,685
+21,011
+41% +$504K ﹤0.01% 1128
2013
Q2
$861K Buy
+50,674
New +$861K ﹤0.01% 1228